BNF for Children 2014 - 2015 (British National Formulary for by Pharmaceutical Press

By Pharmaceutical Press

Show description

Read Online or Download BNF for Children 2014 - 2015 (British National Formulary for Children) PDF

Similar children books

He-Man Smells Trouble

Welcome to the joys and intriguing international of Masters of the Universe tale Books. whatever smells humorous on Eternia. Robots from area land with all of the wisdom within the universe. Can He-Man cease Skeletor from blowing up the secrets and techniques?

The Ewok Who Was Afraid

The Ewok Who was once Afraid (An EWOK experience, chuffed condo)

Waldo, Tell Me About Christ by Hans Wilhelm

Waldo explains to Michael the character of Jesus Christ and is helping him come to appreciate that Christ is his ally and may be with him perpetually.

Extra info for BNF for Children 2014 - 2015 (British National Formulary for Children)

Example text

The nature of the effect of the drug on the infant (pharmacodynamic properties of the drug in the infant). Most medicines given to a mother cause no harm to breast-fed infants and there are few contra-indications to breast-feeding when maternal medicines are necessary. However, administration of some drugs to nursing mothers can harm the infant. In the first week of life, some such as preterm or jaundiced infants are at a slightly higher risk of toxicity. Toxicity to the infant can occur if the drug enters the milk in pharmacologically significant quantities.

2 for preparations in Schedule 2; . 3 for preparations in Schedule 3; . K for preparations in Schedule 4 (Part I); . L for preparations in Schedule 4 (Part II). The principal legal requirements relating to medical prescriptions are listed below (see also Department of Health Guidance, p. 9). Prescription requirements Prescriptions for Controlled Drugs that are subject to prescription requirements1 must be indelible2 and must be signed by the prescriber, be dated, and specify the prescriber’s address.

12 Adverse reactions to drugs Adverse reactions to drugs Prescription-event monitoring In addition to the MHRA’s Yellow Card Scheme, an independent scheme monitors the safety of new medicines using a different approach. The Drug Safety Research Unit identifies patients who have been prescribed selected new medicines and collects data on clinical events in these patients. The data are submitted on a voluntary basis by general practitioners on green forms. org. Newer drugs and vaccines Only limited information is available from clinical trials on the safety of new medicines.

Download PDF sample

Rated 4.75 of 5 – based on 21 votes